Pharma Has a Pull-Through Problem—The Answer is Data

Most market access teams at pharmaceutical and biotech manufacturers have the same problem: evidence ...

New Research Reveals Three Ways Pharma Can Better Prioritize Payer Audiences

The pandemic had a huge impact on the way population health decision-makers (PHDMs) navigate ...

Biosimilars Market Set for Biggest Year Yet in 2023

In perhaps the most significant moment for the U.S. biosimilars market to date, the ...

Innovative Contracting in Europe—A Double Hurdle to Value?

In many markets around the world, but particularly in Europe, there have always been ...